Astrazeneca plc (AZN) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
26/04/21	07:05:03	26 Apr 2021	Tagrisso adjuvant receives positive CHMP opinion	Tagrisso adjuvant receives positive CHMP opinion	RNS
26/04/21	07:00:06	26 Apr 2021	Nirsevimab Phase III trial met primary endpoint	Nirsevimab Phase III trial met primary endpoint	RNS
16/04/21	12:00:10	16 Apr 2021	US clearance of proposed acquisition of Alexion	US clearance of proposed acquisition of Alexion	RNS
14/04/21	07:00:10	14 Apr 2021	Tagrisso approved in China in early lung cancer	Tagrisso approved in China in early lung cancer	RNS
12/04/21	13:00:03	12 Apr 2021	Circular and notice of general meeting	Circular and notice of general meeting	RNS
12/04/21	07:00:08	12 Apr 2021	Update on Farxiga COVID-19 DARE-19 Phase III trial	Update on Farxiga COVID-19 DARE-19 Phase III trial	RNS
01/04/21	15:00:02	1 Apr 2021	Total Voting Rights	Total Voting Rights	RNS
30/03/21	12:15:01	30 Mar 2021	Notice of AGM	Notice of AGM	RNS
25/03/21	15:00:01	25 Mar 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
25/03/21	07:00:09	25 Mar 2021	AZD1222 US Ph3 primary analysis confirms efficacy	AZD1222 US Ph3 primary analysis confirms efficacy	RNS
22/03/21	07:00:08	22 Mar 2021	AstraZeneca US vaccine trial met primary endpoint	AstraZeneca US vaccine trial met primary endpoint	RNS
16/03/21	07:05:05	16 Mar 2021	Divestment of Viela shareholding completed	Divestment of Viela shareholding completed	RNS
16/03/21	07:00:10	16 Mar 2021	US supply agreement for additional AZD7442 doses	US supply agreement for additional AZD7442 doses	RNS
09/03/21	15:00:06	9 Mar 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
04/03/21	15:00:01	4 Mar 2021	Designation of EU home member state	Designation of EU home member state	RNS
03/03/21	07:00:08	3 Mar 2021	US court decision favours Symbicort patents	US court decision favours Symbicort patents	RNS
02/03/21	07:00:03	2 Mar 2021	Further update on roxadustat US regulatory review	Further update on roxadustat US regulatory review	RNS
01/03/21	15:00:01	1 Mar 2021	Total Voting Rights	Total Voting Rights	RNS
22/02/21	07:00:08	22 Feb 2021	Voluntary withdrawal Imfinzi US bladder indication	Voluntary withdrawal Imfinzi US bladder indication	RNS
17/02/21	07:00:11	17 Feb 2021	Lynparza: IDMC recommend early analysis of OlympiA	Lynparza: IDMC recommend early analysis of OlympiA	RNS
16/02/21	11:15:06	16 Feb 2021	Filing of Form 20-F with SEC	Filing of Form 20-F with SEC	RNS
15/02/21	15:00:01	15 Feb 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
15/02/21	11:00:02	15 Feb 2021	Annual Financial Report	Annual Financial Report	RNS
11/02/21	07:01:02	11 Feb 2021	AstraZeneca Non-Executive Board changes	AstraZeneca Non-Executive Board changes	RNS
11/02/21	07:00:03	11 Feb 2021	AZN: full-year 2020 results	AZN: full-year 2020 results	RNS
10/02/21	07:00:04	10 Feb 2021	Divestment of Crestor in Europe completed	Divestment of Crestor in Europe completed	RNS
05/02/21	07:00:02	5 Feb 2021	Update on KESTREL Phase III trial for Imfinzi	Update on KESTREL Phase III trial for Imfinzi	RNS
04/02/21	07:00:03	4 Feb 2021	Forxiga approved in China for heart failure	Forxiga approved in China for heart failure	RNS
01/02/21	15:00:00	1 Feb 2021	Total Voting Rights	Total Voting Rights	RNS
01/02/21	12:15:00	1 Feb 2021	AstraZeneca agrees to divest Viela shareholding	AstraZeneca agrees to divest Viela shareholding	RNS
01/02/21	07:00:09	1 Feb 2021	COVID-19 vaccine authorised for use by the EU	COVID-19 vaccine authorised for use by the EU	RNS
29/01/21	15:16:39	29 Jan 2021	COVID-19 vaccine receives positive opinion in EU	COVID-19 vaccine receives positive opinion in EU	RNS
26/01/21	15:00:04	26 Jan 2021	Block listing application	Block listing application	RNS
26/01/21	07:00:04	26 Jan 2021	Symbicort approved in China for mild asthma	Symbicort approved in China for mild asthma	RNS
25/01/21	07:05:06	25 Jan 2021	Calquence approved in Japan for CLL	Calquence approved in Japan for CLL	RNS
25/01/21	07:00:07	25 Jan 2021	Calquence met primary endpoint against ibrutinib	Calquence met primary endpoint against ibrutinib	RNS
20/01/21	07:00:04	20 Jan 2021	Enhertu approved in the EU for breast cancer	Enhertu approved in the EU for breast cancer	RNS
18/01/21	07:00:07	18 Jan 2021	Enhertu approved in the US for gastric cancer	Enhertu approved in the US for gastric cancer	RNS
15/01/21	07:00:05	15 Jan 2021	Imfinzi new dosing approved in EU	Imfinzi new dosing approved in EU	RNS
06/01/21	07:00:05	6 Jan 2021	Farxiga granted US Priority Review for CKD	Farxiga granted US Priority Review for CKD	RNS
04/01/21	15:00:01	4 Jan 2021	Total Voting Rights	Total Voting Rights	RNS
04/01/21	07:00:10	4 Jan 2021	Atacand divestment in over 70 countries completed	Atacand divestment in over 70 countries completed	RNS
30/12/20	07:00:05	30 Dec 2020	AstraZeneca’s COVID-19 vaccine authorised in UK	AstraZeneca’s COVID-19 vaccine authorised in UK	RNS
29/12/20	07:00:12	29 Dec 2020	Lynparza approved in Japan for three cancers	Lynparza approved in Japan for three cancers	RNS
21/12/20	07:05:04	21 Dec 2020	Tagrisso approved in the US for early lung cancer	Tagrisso approved in the US for early lung cancer	RNS
21/12/20	07:00:06	21 Dec 2020	Update on US regulatory review of roxadustat	Update on US regulatory review of roxadustat	RNS
17/12/20	16:00:02	17 Dec 2020	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
16/12/20	18:15:01	16 Dec 2020	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
15/12/20	07:00:08	15 Dec 2020	Imfinzi new dose receives positive EU CHMP opinion	Imfinzi new dose receives positive EU CHMP opinion	RNS
14/12/20	07:05:07	14 Dec 2020	Trastuzumab deruxtecan positive CHMP	Trastuzumab deruxtecan positive CHMP	RNS

Showing 551–600 of 1,436 announcements

Astrazeneca plc RNS

Astrazeneca plc RNS